<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04757909</url>
  </required_header>
  <id_info>
    <org_study_id>4R17/013</org_study_id>
    <secondary_id>4R18/08</secondary_id>
    <secondary_id>4R17/013</secondary_id>
    <nct_id>NCT04757909</nct_id>
  </id_info>
  <brief_title>Detection of Anemizations in Primary Care.</brief_title>
  <acronym>ANHEMOG</acronym>
  <official_title>Early Detection of Anemizations in Primary Care Using Hemoglobinometer: Randomized Clinical Trial Protocol.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jordi Gol i Gurina Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jordi Gol i Gurina Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To evaluate the effect of the use of the hemoglobinometer in primary care on the&#xD;
      clinical results of patients with chronic anemia.&#xD;
&#xD;
      Methods: The ANHEMOG study is a randomized controlled trial with two parallel arms,&#xD;
      intervention and control. It was approved at december 11, 2017. The study randomizes 138&#xD;
      patients with chronic anemia. In the intervention arm, a monthly capillary hemoglobin&#xD;
      measurement will be performed with a hemoglobinometer. If a decrease in hemoglobin&#xD;
      concentration is detected, an existing transfusion circuit will be followed. Social,&#xD;
      demographic and quality of life variables will be collected from all participants.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      The results of the research will have an impact on people with chronic anemia who would&#xD;
      receive red blood cell transfusion when needed without delay. The improvement in the times of&#xD;
      action would reduce decompensations from chronic diseases, visits to the emergency room and&#xD;
      hospital admissions, and therefore would improve the quality of life of these patients.&#xD;
      Furthermore, the management of the different interventions by the Case Management Nurse&#xD;
      (EGC), in this regard, improves the current fragmentation of the different levels of care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Number of hospital admissions</measure>
    <time_frame>6 and 12 months.</time_frame>
    <description>Anual mean of hospital admissions caused by haemoglobin concentration decline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Number of visits to the emergency room</measure>
    <time_frame>6 and 12 months.</time_frame>
    <description>Anual mean of visits to the emergency room caused by haemoglobin concentration decline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life self-assessment.</measure>
    <time_frame>6 and 12 months.</time_frame>
    <description>WHOQOL-BREF questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with the intervention.</measure>
    <time_frame>6 and 12 months.</time_frame>
    <description>Ad-hoc questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">33</enrollment>
  <condition>Anemia</condition>
  <condition>Red Blood Cell Transfusion</condition>
  <arm_group>
    <arm_group_label>Monthly Haemoglobinometry</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine monitoring</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Monthly Haemoglobinometry</intervention_name>
    <description>Monthly measurement of capillary hemoglobin with non-invasive techniques in primary health care.&#xD;
Inclusion in a transfusion circuit with referral to a hospital day hospital if necessary.</description>
    <arm_group_label>Monthly Haemoglobinometry</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  People over 40 years old&#xD;
&#xD;
          -  Had received 2 or more red blood cell transfusions due to chronic disease, during a&#xD;
             year.&#xD;
&#xD;
          -  The health provider in Primary Care is the Institut Català de la Salut.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presenting kidney failure on hemodialysis treatment.&#xD;
&#xD;
          -  Being in palliative care situation&#xD;
&#xD;
          -  Presenting a moderate-severe cognitive impairment, with a Pfeiffer scale score higher&#xD;
             than 5.&#xD;
&#xD;
          -  Not having a caregiver able to detect signs of decompensation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boris Trenado Luengo, RN</last_name>
    <phone>0034 93384 24 25</phone>
    <email>btrenado.mn.ics@gencat.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pere Toran-Montserrat, MD</last_name>
    <phone>003493 741 53 38</phone>
    <email>ptoran.bnm.ics@gencat.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CAP La Llàntia</name>
      <address>
        <city>Mataró</city>
        <state>Barcelona</state>
        <zip>08303</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Haemoglobinometry</keyword>
  <keyword>Primary Care Nursing,</keyword>
  <keyword>Advanced Practice Nursing</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Study protocol will be sent to publication in the next months</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Open access to read as soon as published</ipd_time_frame>
    <ipd_access_criteria>Open</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

